MOTS-c (MOTSC)

Metabolic Preclinical

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a mitochondria-derived peptide (MDP) encoded within the mitochondrial genome. Discovered in 2015, MOTS-c is a 16-amino acid peptide that plays a significant role in metabolic regulation and exercise physiology. The peptide enhances insulin sensitivity, promotes glucose uptake, and activates the AMPK pathway. MOTS-c is released from mitochondria and can act in an endocrine manner, affecting distant tissues. Levels of MOTS-c decline with age and are lower in individuals with type 2 diabetes and metabolic syndrome. Exercise increases circulating MOTS-c levels, suggesting it mediates some beneficial effects of physical activity.

Key Data

Research Status
Preclinical
Half-Life
Unknown
Administration
Subcutaneous injection
Typical Dosage
5-10 mg weekly
Molecular Weight
2,174 Da
Molecular Formula
C100H152N28O23S2

Mechanism of Action

Activates AMPK pathway, improves glucose regulation, enhances mitochondrial function and metabolic flexibility.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home